Directorate update
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your KLR notes
The Board of Keller Group plc today announces that our Chief Executive Officer, Michael Speakman, will be undergoing necessary medical treatment. Michael will continue in his role with the support of David Burke, Chief Financial Officer, the Executive Committee and the Chairman. Michael will remain actively engaged in key strategic decisions and day-to-day leadership. The Board and the entire company are fully supportive of Michael during this period.
This notification is made in accordance with paragraph 9.6.11R of the Listing Rules of the Financial Conduct Authority.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.